{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T21:05:37Z","timestamp":1779483937874,"version":"3.53.1"},"reference-count":64,"publisher":"Elsevier","isbn-type":[{"value":"9780443524349","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.apcsb.2026.02.005","type":"book-chapter","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T20:44:34Z","timestamp":1774989874000},"page":"55-76","source":"Crossref","is-referenced-by-count":0,"title":["Investigating the immune-modulatory association of miRNAs in HPV-associated HNSCC individuals: A bioinformatics approach"],"prefix":"10.1016","author":[{"given":"Ankur","family":"Datta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Muthu Meenakshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Varshaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Priya Doss","family":"C","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/bs.apcsb.2026.02.005_bib1","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3390\/biomedicines10030663","article-title":"Impact of miR-1\/miR-133 clustered miRNAs: PFN2 facilitates malignant phenotypes in head and neck squamous cell carcinoma","volume":"10","author":"Asai","year":"2022","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/bs.apcsb.2026.02.005_bib2","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.3390\/cancers15092651","article-title":"Role of PET\/CT in oropharyngeal cancers","volume":"15","author":"Avery","year":"2023","journal-title":"Cancers"},{"issue":"D1","key":"10.1016\/bs.apcsb.2026.02.005_bib3","doi-asserted-by":"crossref","first-page":"D991","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: Archive for functional genomics data sets\u2014update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Research"},{"issue":"5","key":"10.1016\/bs.apcsb.2026.02.005_bib4","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1128\/jvi.65.5.2254-2260.1991","article-title":"Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation","volume":"65","author":"Bedell","year":"1991","journal-title":"Journal of Virology"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.02.005_bib5","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1038\/s41598-019-38797-z","article-title":"Genome-wide miRNA profiling reinforces the importance of miR-9 in human papillomavirus associated oral and oropharyngeal head and neck cancer","volume":"9","author":"Bo\u017einovi\u0107","year":"2019","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.apcsb.2026.02.005_bib6","series-title":"Transcription factor regulatory networks","first-page":"185","article-title":"MicroRNA regulatory network analysis using miRNet 2.0","author":"Chang","year":"2023"},{"issue":"24","key":"10.1016\/bs.apcsb.2026.02.005_bib7","doi-asserted-by":"crossref","first-page":"6252","DOI":"10.3390\/cancers13246252","article-title":"miR-150-5p-Containing extracellular vesicles are a new immunoregulator that favor the progression of lung cancer in hypoxic microenvironments by altering the phenotype of NK cells","volume":"13","author":"Chang","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/bs.apcsb.2026.02.005_bib8","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.bjorl.2023.03.003","article-title":"MicroRNA-150-5p inhibits the proliferation and invasion of human larynx epidermiod cancer cells though regulating peptidyl-prolyl cis\/trans isomerase","volume":"89","author":"Chen","year":"2023","journal-title":"Brazilian Journal of Otorhinolaryngology"},{"key":"10.1016\/bs.apcsb.2026.02.005_bib9","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6529255","article-title":"Synthetic evaluation of microRNA-1-3p expression in head and neck squamous cell carcinoma based on microarray chips and microRNA sequencing","volume":"2021","author":"Chen","year":"2021","journal-title":"BioMed Research International"},{"issue":"D1","key":"10.1016\/bs.apcsb.2026.02.005_bib10","doi-asserted-by":"crossref","first-page":"D127","DOI":"10.1093\/nar\/gkz757","article-title":"miRDB: An online database for prediction of functional microRNA targets","volume":"48","author":"Chen","year":"2020","journal-title":"Nucleic Acids Research"},{"issue":"8","key":"10.1016\/bs.apcsb.2026.02.005_bib11","first-page":"1411","article-title":"Systemic investigation identifying salivary miR-196b as a promising biomarker for early detection of head-neck cancer and oral precancer lesions","volume":"11","author":"Cheng","year":"2021","journal-title":"Diagnostics (Basel, Switzerland)"},{"issue":"4","key":"10.1016\/bs.apcsb.2026.02.005_bib12","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.3892\/etm.2016.3043","article-title":"miR-133b, a microRNA targeting S1PR1, suppresses nasopharyngeal carcinoma cell proliferation","volume":"11","author":"Cheng","year":"2016","journal-title":"Experimental and Therapeutic Medicine"},{"key":"10.1016\/bs.apcsb.2026.02.005_bib13","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.intimp.2019.05.029","article-title":"MicroRNA-206 promotes lipopolysaccharide-induced inflammation injury via regulation of IRAK1 in MRC-5 cells","volume":"73","author":"Chu","year":"2019","journal-title":"International Immunopharmacology"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.02.005_bib14","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12903-015-0111-x","article-title":"Detection of HPV in oral rinse samples from OPSCC and non-OPSCC patients","volume":"15","author":"Dang","year":"2015","journal-title":"BMC Oral Health"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.02.005_bib15","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1515\/biol-2020-0058","article-title":"Upregulation of miR-150-5p alleviates LPS-induced inflammatory response and apoptosis of RAW264.7 macrophages by targeting Notch1","volume":"15","author":"Deng","year":"2020","journal-title":"Open Life Sciences"},{"issue":"4","key":"10.1016\/bs.apcsb.2026.02.005_bib16","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3390\/cancers12040936","article-title":"Circulating miR-21 as a potential biomarker for the diagnosis of oral cancer: A systematic review with meta-analysis","volume":"12","author":"Dioguardi","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.02.005_bib17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/cncy.22497","article-title":"Liquid biopsy for the diagnosis of HPV-associated head and neck cancer","volume":"130","author":"Faden","year":"2022","journal-title":"Cancer Cytopathology"},{"issue":"26","key":"10.1016\/bs.apcsb.2026.02.005_bib18","first-page":"E6030","article-title":"YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics","volume":"115","author":"Fan","year":"2018","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/bs.apcsb.2026.02.005_bib19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bbrc.2016.06.038","article-title":"MicroRNA-206 regulates the secretion of inflammatory cytokines and MMP9 expression by targeting TIMP3 in Mycobacterium tuberculosis-infected THP-1 human macrophages","volume":"477","author":"Fu","year":"2016","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"3","key":"10.1016\/bs.apcsb.2026.02.005_bib20","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3390\/cancers15030656","article-title":"Accuracy of p16 IHC in classifying HPV-Driven OPSCC in different populations","volume":"15","author":"Gallus","year":"2023","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/bs.apcsb.2026.02.005_bib21","first-page":"219","article-title":"MicroRNAs in the regulation of immune response in cardiovascular diseases: New diagnostic and therapeutic tools","volume":"24","author":"Gareev","year":"2025","journal-title":"Gene Expression"},{"issue":"29","key":"10.1016\/bs.apcsb.2026.02.005_bib22","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1200\/JCO.2015.61.6995","article-title":"Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma","volume":"33","author":"Gillison","year":"2015","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.02.005_bib23","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.transproceed.2020.05.024","article-title":"MicroRNA-142-5p is up-regulated on allogeneic immune responses and up-regulates MHC class II expression in human umbilical vein endothelial cells","volume":"53","author":"Han","year":"2021","journal-title":"Transplantation Proceedings"},{"issue":"10","key":"10.1016\/bs.apcsb.2026.02.005_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e08086","article-title":"MicroRNA 142-5p promotes tumor growth in oral squamous cell carcinoma via the PI3K\/AKT pathway by regulating PTEN","volume":"7","author":"Iizumi","year":"2021","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/bs.apcsb.2026.02.005_bib25","first-page":"250","article-title":"MicroRNA-150-5P regulates Th1\/Th2 cytokines expression levels by targeting EGR2 in allergic rhinitis","volume":"62","author":"Jian","year":"2024","journal-title":"Rhinology"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.02.005_bib26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","article-title":"Head and neck squamous cell carcinoma","volume":"6","author":"Johnson","year":"2020","journal-title":"Nature Reviews. Disease Primers"},{"issue":"4","key":"10.1016\/bs.apcsb.2026.02.005_bib27","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.anl.2017.11.019","article-title":"Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma","volume":"45","author":"Koshizuka","year":"2018","journal-title":"Auris, Nasus, Larynx"},{"issue":"8","key":"10.1016\/bs.apcsb.2026.02.005_bib28","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3390\/biom14080925","article-title":"The next chapter in cancer diagnostics: Advances in HPV-positive head and neck cancer","volume":"14","author":"Krsek","year":"2024","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/bs.apcsb.2026.02.005_bib29","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41571-022-00603-7","article-title":"HPV-associated oropharyngeal cancer: Epidemiology, molecular biology and clinical management","volume":"19","author":"Lechner","year":"2022","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"23\u201324","key":"10.1016\/bs.apcsb.2026.02.005_bib30","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1089\/hum.2020.090","article-title":"Antioncogenic effect of microRNA-206 on neck squamous cell carcinoma through inhibition of proliferation and promotion of apoptosis and autophagy","volume":"31","author":"Li","year":"2020","journal-title":"Human Gene Therapy"},{"issue":"6","key":"10.1016\/bs.apcsb.2026.02.005_bib31","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/s41418-018-0208-2","article-title":"EZH2-DNMT1-mediated epigenetic silencing of miR-142-3p promotes metastasis through targeting ZEB2 in nasopharyngeal carcinoma","volume":"26","author":"Li","year":"2019","journal-title":"Cell Death and Differentiation"},{"issue":"5","key":"10.1016\/bs.apcsb.2026.02.005_bib32","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.21037\/apm-20-1391","article-title":"The correlations between the serum expression of miR-206 and the severity and prognosis of sepsis","volume":"9","author":"Liang","year":"2020","journal-title":"Annals of Palliative Medicine"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.02.005_bib33","article-title":"Correlation and prognosis analysis of human papillomavirus infection and P16 expression in oral and oropharyngeal squamous cell carcinomas","volume":"15","author":"Lin","year":"2025","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.apcsb.2026.02.005_bib34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.biopha.2017.08.145","article-title":"MiR-206 inhibits head and neck squamous cell carcinoma cell progression by targeting HDAC6 via PTEN\/AKT\/mTOR pathway","volume":"96","author":"Liu","year":"2017","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.02.005_bib35","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1056\/NEJMe1003607","article-title":"Prognostic implications of HPV in oropharyngeal cancer","volume":"363","author":"Lowy","year":"2010","journal-title":"The New England Journal of Medicine"},{"issue":"22","key":"10.1016\/bs.apcsb.2026.02.005_bib36","doi-asserted-by":"crossref","first-page":"649","DOI":"10.21037\/atm.2019.10.85","article-title":"MicroRNA-142-3p inhibits IFN-\u03b3 production via targeting of RICTOR in Aspergillus fumigatus activated CD4+ T cells","volume":"7","author":"Ma","year":"2019","journal-title":"Annals of Translational Medicine"},{"issue":"1\u20132","key":"10.1016\/bs.apcsb.2026.02.005_bib37","doi-asserted-by":"crossref","first-page":"29","DOI":"10.18632\/oncotarget.213","article-title":"miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma","volume":"2","author":"Nohata","year":"2011","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/bs.apcsb.2026.02.005_bib38","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.oraloncology.2012.06.019","article-title":"Human papillomavirus related head and neck cancer survival: A systematic review and meta-analysis","volume":"48","author":"O\u2019Rorke","year":"2012","journal-title":"Oral Oncology"},{"issue":"04","key":"10.1016\/bs.apcsb.2026.02.005_bib39","doi-asserted-by":"crossref","DOI":"10.4172\/2324-9110.1000191","article-title":"Expression of circulating Mir-206 in patients with lung and head and neck cancers and its association with cancer cachexia","volume":"06","author":"Sutandyo","year":"2017","journal-title":"Journal of Clinical & Experimental Oncology"},{"issue":"6","key":"10.1016\/bs.apcsb.2026.02.005_bib40","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1111\/cas.15345","article-title":"Promotion of tumorigenesis by miR-1260b-targeting CASP8: Potential diagnostic and prognostic marker for breast cancer","volume":"113","author":"Park","year":"2022","journal-title":"Cancer Science"},{"issue":"2","key":"10.1016\/bs.apcsb.2026.02.005_bib41","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.pathol.2019.10.008","article-title":"Human papilloma virus related squamous cell carcinomas of the head and neck: Diagnosis, clinical implications and detection of HPV","volume":"52","author":"Paver","year":"2020","journal-title":"Pathology"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.02.005_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-20338-w","article-title":"Global microRNA expression profile in laryngeal carcinoma unveils new prognostic biomarkers and novel insights into field cancerization","volume":"12","author":"Popov","year":"2022","journal-title":"Scientific Reports"},{"issue":"5","key":"10.1016\/bs.apcsb.2026.02.005_bib43","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.oraloncology.2013.12.019","article-title":"Epidemiology of HPV-associated oropharyngeal cancer","volume":"50","author":"Pytynia","year":"2014","journal-title":"Oral Oncology"},{"issue":"4","key":"10.1016\/bs.apcsb.2026.02.005_bib44","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1159\/000490932","article-title":"MicroRNA-142-3p Induces atherosclerosis-associated endothelial cell apoptosis by directly targeting rictor","volume":"47","author":"Qin","year":"2018","journal-title":"Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.02.005_bib45","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1182\/blood-2012-05-428938","article-title":"SOX4 enables oncogenic survival signals in acute lymphoblastic leukemia","volume":"121","author":"Ramezani-Rad","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.02.005_bib46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.canlet.2013.02.036","article-title":"Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer","volume":"335","author":"Seshacharyulu","year":"2013","journal-title":"Cancer Letters"},{"issue":"11","key":"10.1016\/bs.apcsb.2026.02.005_bib47","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: A software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Research"},{"key":"10.1016\/bs.apcsb.2026.02.005_bib48","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.dci.2017.08.001","article-title":"Immunomodulation: A definitive role of microRNA-142","volume":"77","author":"Sharma","year":"2017","journal-title":"Developmental and Comparative Immunology"},{"issue":"6","key":"10.1016\/bs.apcsb.2026.02.005_bib49","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1006\/scbi.1999.0141","article-title":"Human papillomavirus life cycle: Active and latent phases","volume":"9","author":"Stubenrauch","year":"1999","journal-title":"Seminars in Cancer Biology"},{"issue":"W1","key":"10.1016\/bs.apcsb.2026.02.005_bib50","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: An enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Research"},{"issue":"5","key":"10.1016\/bs.apcsb.2026.02.005_bib51","first-page":"1071","article-title":"Diagnostics of HNSCC patients: An analysis of cell lines and patient-derived xenograft models for personalized therapeutical medicine","volume":"12","author":"Ursu","year":"2022","journal-title":"Diagnostics (Basel, Switzerland)"},{"issue":"59","key":"10.1016\/bs.apcsb.2026.02.005_bib52","doi-asserted-by":"crossref","first-page":"99990","DOI":"10.18632\/oncotarget.21725","article-title":"Salivary miRNA panel to detect HPV-positive and HPV-negative head and neck cancer patients","volume":"8","author":"Wan","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/bs.apcsb.2026.02.005_bib53","first-page":"128","article-title":"Plasma microRNA profiling highlights miR-1260b and miR-720 as novel diagnostic and prognostic biomarkers of esophageal squamous cell carcinoma","volume":"5","author":"Wang","year":"2021","journal-title":"Blood&Genomics"},{"issue":"3","key":"10.1016\/bs.apcsb.2026.02.005_bib54","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1139\/bcb-2017-0015","article-title":"MicroRNA-1-3p inhibits the proliferation and migration of oral squamous cell carcinoma cells by targeting DKK1","volume":"96","author":"Wang","year":"2018","journal-title":"Biochemistry and Cell Biology = Biochimie et Biologie Cellulaire"},{"key":"10.1016\/bs.apcsb.2026.02.005_bib55","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2485055","article-title":"Downregulated miR-150-5p in the tissue of nasopharyngeal carcinoma","volume":"2022","author":"Wen","year":"2022","journal-title":"Genetics Research"},{"key":"10.1016\/bs.apcsb.2026.02.005_bib56","series-title":"Ggplot2","author":"Wickham","year":"2016"},{"issue":"2","key":"10.1016\/bs.apcsb.2026.02.005_bib57","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41419-019-1390-y","article-title":"miR-1260b, mediated by YY1, activates KIT signaling by targeting SOCS6 to regulate cell proliferation and apoptosis in NSCLC","volume":"10","author":"Xia","year":"2019","journal-title":"Cell Death & Disease"},{"issue":"3","key":"10.1016\/bs.apcsb.2026.02.005_bib58","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.3390\/curroncol31030099","article-title":"ITGAV promotes the progression of head and neck squamous cell carcinoma","volume":"31","author":"Xu","year":"2024","journal-title":"Current Oncology (Toronto, Ont.)"},{"issue":"24","key":"10.1016\/bs.apcsb.2026.02.005_bib59","first-page":"12717","article-title":"Inhibition of miR-133b indicates poor prognosis and promotes progression of OSCC via SOX4","volume":"24","author":"Yang","year":"2020","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"3","key":"10.1016\/bs.apcsb.2026.02.005_bib60","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/WNR.0b013e32834fab06","article-title":"Expression of brain-derived neurotrophic factor (BDNF) is regulated by the Wnt signaling pathway","volume":"23","author":"Yi","year":"2012","journal-title":"Neuroreport"},{"issue":"12","key":"10.1016\/bs.apcsb.2026.02.005_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e11995","article-title":"Immune cell-derived extracellular vesicular microRNAs induce pancreatic beta cell apoptosis","volume":"8","author":"Yu","year":"2022","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.02.005_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-10695-2","article-title":"MicroRNA profiling study reveals miR-150 in association with metastasis in nasopharyngeal carcinoma","volume":"7","author":"Yue","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.apcsb.2026.02.005_bib63","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.biopha.2018.12.057","article-title":"miR-133b inhibits cell proliferation, migration and invasion of esophageal squamous cell carcinoma by targeting EGFR","volume":"111","author":"Zeng","year":"2019","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"issue":"1","key":"10.1016\/bs.apcsb.2026.02.005_bib64","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.1038\/s41598-022-21447-2","article-title":"MicroRNA-142-3p promotes renal cell carcinoma progression by targeting RhoBTB3 to regulate HIF-1 signaling and GGT\/GSH pathways","volume":"13","author":"Zhang","year":"2023","journal-title":"Scientific Reports"}],"container-title":["Advances in Protein Chemistry and Structural Biology","Immunomodulators - Part B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876162326000179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876162326000179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T20:21:27Z","timestamp":1779481287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876162326000179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443524349"],"references-count":64,"URL":"https:\/\/doi.org\/10.1016\/bs.apcsb.2026.02.005","relation":{},"ISSN":["1876-1623"],"issn-type":[{"value":"1876-1623","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}